Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 29, 2022

SELL
$0.55 - $0.98 $111,455 - $198,594
-202,647 Closed
0 $0
Q4 2021

Feb 07, 2022

SELL
$0.9 - $1.31 $50,149 - $72,995
-55,722 Reduced 21.57%
202,647 $200,000
Q3 2021

Nov 01, 2021

BUY
$1.21 - $1.61 $88,897 - $118,285
73,469 Added 39.73%
258,369 $331,000
Q2 2021

Aug 12, 2021

BUY
$1.6 - $2.02 $231,651 - $292,459
144,782 Added 360.89%
184,900 $301,000
Q1 2021

May 13, 2021

BUY
$1.86 - $2.87 $13,667 - $21,088
7,348 Added 22.42%
40,118 $79,000
Q4 2020

Feb 04, 2021

BUY
$1.65 - $2.43 $54,070 - $79,631
32,770 New
32,770 $68,000
Q3 2020

Nov 09, 2020

SELL
$1.6 - $2.35 $171,763 - $252,277
-107,352 Closed
0 $0
Q2 2020

Jul 20, 2020

BUY
$1.33 - $2.76 $142,778 - $296,291
107,352 New
107,352 $249,000
Q1 2020

Apr 30, 2020

SELL
$0.97 - $2.85 $94,862 - $278,718
-97,796 Closed
0 $0
Q4 2019

Jan 28, 2020

SELL
$1.69 - $3.8 $54 - $121
-32 Reduced 0.03%
97,796 $372,000
Q3 2019

Nov 04, 2019

SELL
$0.61 - $2.21 $8,286 - $30,020
-13,584 Reduced 12.19%
97,828 $180,000
Q2 2019

Jul 29, 2019

SELL
$0.51 - $0.86 $83,153 - $140,220
-163,047 Reduced 59.41%
111,412 $73,000
Q1 2019

Apr 29, 2019

BUY
$0.51 - $0.82 $68,194 - $109,645
133,714 Added 95.0%
274,459 $172,000
Q4 2018

Feb 01, 2019

BUY
$0.48 - $1.1 $59,941 - $137,365
124,878 Added 787.03%
140,745 $68,000
Q3 2018

Nov 06, 2018

SELL
$1.06 - $1.69 $15,986 - $25,488
-15,082 Reduced 48.73%
15,867 $17,000
Q2 2018

Aug 07, 2018

BUY
$1.56 - $2.51 $15,433 - $24,831
9,893 Added 46.98%
30,949 $48,000
Q1 2018

May 03, 2018

SELL
$0.91 - $2.24 $152,217 - $374,689
-167,272 Reduced 88.82%
21,056 $45,000
Q4 2017

Jan 24, 2018

BUY
$0.78 - $2.1 $134,604 - $362,397
172,570 Added 1095.13%
188,328 $174,000
Q3 2017

Nov 07, 2017

BUY
$1.55 - $1.82 $24,424 - $28,679
15,758
15,758 $28,000

Others Institutions Holding DRRX

About DURECT CORP


  • Ticker DRRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 227,794,000
  • Market Cap $223M
  • Description
  • DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...
More about DRRX
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.